Search

Your search keyword '"D’Amato, D"' showing total 18 results

Search Constraints

Start Over You searched for: Author "D’Amato, D" Remove constraint Author: "D’Amato, D" Journal digestive and liver disease Remove constraint Journal: digestive and liver disease
18 results on '"D’Amato, D"'

Search Results

1. T.05.4: RENAL LITHOGENIC RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATES WITH MICROBIOTA COMPOSITION, URINARY PROFILE AND DIETARY INTAKE

2. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort

3. A nutrigenetic precision approach for the management of NAFLD

6. T.07.3 PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION

7. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

8. Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease

9. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study

10. Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease

11. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

12. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

13. PC.01.8 RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

14. Radiomics-based model for outcome prediction in primary sclerosing cholangitis

15. Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid

16. Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group

18. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

Catalog

Books, media, physical & digital resources